S J Meggitt
Overview
Explore the profile of S J Meggitt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guckian J, Sridhar A, Meggitt S
Clin Exp Dermatol
. 2019 Jul;
45(2):153-158.
PMID: 31276227
Background: A UK dermatology curricula review has suggested that undergraduate delivery relies on lectures and is subject to clinical and staffing pressures. Many UK undergraduate students feel less than adequately...
2.
3.
Winn R, Miller J, Meggitt S
Clin Exp Dermatol
. 2018 May;
43(8):927-928.
PMID: 29808483
No abstract available.
4.
Winn R, Brass D, Meggitt S
J Eur Acad Dermatol Venereol
. 2018 Mar;
32(9):e355-e357.
PMID: 29524254
No abstract available.
5.
Al-Rawi H, Meggitt S, Williams F, Wahie S
Lupus
. 2017 Sep;
27(5):847-852.
PMID: 28862574
Background Hydroxychloroquine (HCQ), a 4-aminoquinolone antimalarial, is regarded as the oral therapy of choice for cutaneous and systemic lupus erythematosus (SLE). It is also licensed for rheumatoid arthritis (RA). Studies...
6.
Reynolds N, Sinha A, Elias M, Meggitt S
Br J Dermatol
. 2016 Sep;
175 Suppl 2:8-12.
PMID: 27667309
This review considers, in the context of British Skin Foundation (BSF)-funded translational research into atopic eczema conducted in Newcastle, the complex interactions between clinical and non-clinical scientists in both academia...
7.
Wahie S, Meggitt S
Br J Dermatol
. 2013 Apr;
169(3):653-9.
PMID: 23581274
Background: The recommended first-line oral therapy for discoid lupus erythematosus (DLE) is the antimalarial hydroxychloroquine. To the best of our knowledge, there is no published information regarding the long-term (i.e....
8.
Meggitt S, Anstey A, Mohd Mustapa M, Reynolds N, Wakelin S
Br J Dermatol
. 2011 Sep;
165(4):711-34.
PMID: 21950502
No abstract available.
9.
Wahie S, McColl E, Reynolds N, Meggitt S
Br J Dermatol
. 2010 Sep;
164(1):221-2.
PMID: 20874790
No abstract available.
10.
Wahie S, McColl E, Reynolds N, Meggitt S
Br J Dermatol
. 2010 Mar;
162(5):1030-7.
PMID: 20199547
Background: Discoid lupus erythematosus (DLE) is a disfiguring inflammatory skin disease. There is no specific tool for measuring disease severity. Objectives: To determine the features needed in a score measuring...